Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. The company is headquartered in Melbourne, Victoria and currently employs 282 full-time employees. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.
Follow-Up Questions
What is the price performance of CALZF stock?
The current price of CALZF is $0.89, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Polynovo Ltd?
Polynovo Ltd belongs to Health Care industry and the sector is Health Care
What is Polynovo Ltd market cap?
Polynovo Ltd's current market cap is $614.8M
Is Polynovo Ltd a buy, sell, or hold?
According to wall street analysts, 11 analysts have made analyst ratings for Polynovo Ltd, including 3 strong buy, 6 buy, 3 hold, 0 sell, and 3 strong sell
